NCT07365215 (PADI) is a clinical trial in Pediatric Delirium, sponsored by Uppsala University.

Who is sponsoring NCT07365215?

NCT07365215 is sponsored by Uppsala University.

What condition does NCT07365215 study?

NCT07365215 studies Pediatric Delirium, Pediatric Intensive Care, Risk Factors.

Is NCT07365215 still recruiting?

NCT07365215 is currently completed. Last updated 26 January 2026.

Last reviewed 2026-01-26 · How we verify

NCT07365215: PADI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pediatric Delirium in Swedish Paediatric Intensive Care Units

Completed Last updated 26 January 2026

What this trial tests

trial in Pediatric Delirium in 676 participants. Completed in 30 June 2025.

Timeline

1 December 2023

Primary endpoint
30 June 2025

30 June 2025

Quick facts

Lead sponsor	Uppsala University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	676
Start date	1 December 2023
Primary completion	30 June 2025
Estimated completion	30 June 2025
Sites	3 locations across Sweden

Conditions studied

Pediatric Delirium — all drugs for Pediatric Delirium →
Pediatric Intensive Care — all drugs for Pediatric Intensive Care →
Risk Factors — all drugs for Risk Factors →

Sponsor

Uppsala University

Who can join

Under 18, any sex, with Pediatric Delirium or Pediatric Intensive Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This observational study aims to determine the incidence of delirium among children in a pediatric intensive care unit (PICU) and to identify associated risk factors. Research Questions: What is the incidence of delirium among children in a pediatric intensive care unit? What are the identifiable risk factors that predispose children in a pediatric intensive care unit to developing delirium?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Uppsala University trials

Trials by the same sponsor.

NCT07517185 — The HIt HArd and hiT Early in Multiple Sclerosis Trial · Phase 2 · not yet recruiting
NCT07351149 — Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery · recruiting
NCT07461636 — Robotic-Assisted Pedicle Screw Placement in Spine Surgery · recruiting
NCT07273409 — Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not · NA · recruiting
NCT07352683 — Open TAP-block in Pediatric Abdominal Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07365215 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Uppsala University
Last refreshed: 26 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07365215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing